Evidence map›Paper›PMID 42635491›Full record

ArticleVirulence2026

Phage anti-defense genes targeting NAD

Bingbing Lei, Yueren Xu, Keyu Zhu, Kexuan Gao, Yuhui Li, Xia Li, Xinyao Xu, Hui Li, Ruirui Hu, Yue Wang and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bingbing LeiCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Yueren XuCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Keyu ZhuCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Kexuan GaoCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Yuhui LiInstitute of Agro-Product Processing, Xinjiang Academy of Agricultural and Reclamation Science, Xinjiang, Shihezi, China.
Xia LiDepartment of Opthalmic Center, Xinjiang 474 Hospital, Xinjiang, Urumqi, China.
Xinyao XuCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Hui LiCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Ruirui HuCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Yue WangCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Jihong DaiCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Zhenghao LiCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Yuanmeng LvCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Wenjing GeCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Wei NiCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.
Shengwei HuCollege of Life Sciences, Shihezi University, Shihezi, Xinjiang, China.ORCID 0000-0001-8849-265X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phage therapy for drug-resistant

Indexed as

BacteriophagesDNA ReplicationHost SpecificityKlebsiella pneumoniaeNADAnimalsBacteremiaKlebsiella InfectionsMiceNicotinamide-Nucleotide AdenylyltransferaseNADNicotinamide-Nucleotide AdenylyltransferaseBroad-host-range phageKlebsiella pneumoniaephage anti-defense genesphage therapy

Identifiers

PMID42635491
PMCPMC13505451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.